Press Releases

The search for effective drugs against the new coronavirus is currently a top priority at the German Center for Infection Research (DZIF). Developing inhibitors of viral replication is a promising

Currently, little is known about children and their susceptibility to the new coronavirus. It has been observed that young children have rarely presented with COVID-19 up to now. No specific

An international consortium found a remarkable global spread of strains of a multi-resistant bacterium that can cause severe infections – Stenotrophomonas maltophilia. The study, published under the

MHH professor and DZIF scientist Thomas Pietschmann leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in

Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths. These include the SARS coronavirus outbreak in 2002

Alongside developing vaccines, scientists at the German Center for Infection Research (DZIF) are working at high speed to develop new drugs to improve the treatment of COVID-19 patients. A DZIF

In the global fight against the new coronavirus, an increasing number of clinical trials are being conducted on drugs to fight the virus in many countries of the world including Germany. In order to

A top global priority is to find agents that can stop the severe course of COVID-19 infection and consequently increase the chances of patient survival as rapidly as possible. Specific tests have

A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings